TCS Q1: revenue up ~14% YoY to ₹72,275 Cr; ₹668 Cr legal hit and soft margins cap PAT at ₹13,420 Cr

TCS opened FY27 with consolidated revenue of ₹72,275 Cr for the June quarter, up 13.9% YoY (vs ₹63,437 Cr) but only 2.2% sequentially — a topline that edged past the street's ~₹72,012 Cr estimate. Consolidated profit for the period was ₹13,420 Cr (₹13,349 Cr attributable to shareholders), up just 4.6% YoY and down 2.6% QoQ. The gap between double-digit revenue growth and near-flat profit is largely a one-off: the quarter absorbed a ₹668 Cr exceptional 'settlement of legal claim' (the CSC/US$70m Texas judgement after the US Supreme Court denied TCS's petition on June 15, 2026), plus ~₹69 Cr of related interest in finance costs. Stripping the ₹668 Cr exceptional out, adjusted PAT growth is ~9.9% YoY — steady rather than strong, and still trailing the 13.9% revenue line.

Margins are the soft spot. Net margin fell to 18.6% (from 19.7% a year ago and 19.3% last quarter), and operating margin (ex-other income and exceptional) sits at ~24%, below management's stated aspiration of exiting at 25%-plus — the squeeze shows up in employee costs (₹42,137 Cr, up on resumed hiring) and higher other expenses, consistent with the 'revenue slows, margins compress as hiring resumes' read from the print. Standalone told a similar story: revenue ₹59,553 Cr, PAT ₹13,642 Cr, both carrying the same ₹668 Cr charge. Standalone and consolidated growth do not diverge materially, so neither number contradicts the other.

The stock went into the print at ₹2,302, up 2.6% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

Growth was broad-based across verticals — BFSI (the largest segment) rose to ₹27,990 Cr revenue with ₹7,177 Cr segment result, and CMT and Life Sciences also grew — supporting management's Q1-concall framing that AI-led transformation and order-book closures are driving demand despite near-term geopolitical and client-spend headwinds. That framing largely held: revenue confirmed the confidence, but the ~24% operating margin fell short of the 25%-plus bar management set for itself. This quarter's corporate cadence (agentic-AI drug-development platform, Vodafone Business UK deal, Google Cloud centres in Mexico/Kolkata) is consistent with the AI-order narrative but is not yet quantified in the segment numbers. The board declared an interim dividend of ₹12/share (record date July 15, 2026); separately, Tata Sons chairman N. Chandrasekaran is set to step down in Feb 2027, a governance overhang unrelated to the print.